MedTrace Logo

Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy

NCT04413487 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-06-04

No results posted yet for this study

Summary

Subjects will include patients diagnosed with breast cancer or hematological cancer who are planned for chemotherapy treatment with anthracycline or trastuzumab; and who have one or more risk factors for cardiovascular disease. Subjects will received an extra echocardiogram to determine if heart problems can be detected earlier.

Conditions

Interventions

OTHER

Extra echocardiogram

Subjects will receive an extra echocardiogram after 2 cycles of chemotherapy

Sponsors & Collaborators

  • The Guthrie Clinic

    lead OTHER

Principal Investigators

  • Philip Lowry, MD · The Guthrie Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2020-05-28
Completion
2020-05-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413487 on ClinicalTrials.gov